Clinscience, Experior CROs Merge in Europe
European CRO Clinscience has acquired CRO Experior, to increase its global capabilities. For 20 years, Experior has activities Spain, Italy, Portugal, France, the UK and the Benelux countries, with a oncology, neurology, infectious and autoimmune diseases, and a knowledge of the development of research projects in the field of ATMP - advanced medical technologies. In a statement, the merger complements both companies in terms of competences and geographical range, and continues the qualities of building value for our clients, focusing attention around the patient, and service technology.
For more information, click here.
Semaglutide Significantly Improves Steatohepatitis, Fibrosis in Phase III MASH Trial
May 2nd 2025Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly semaglutide improved liver histology, metabolic markers, and weight loss in patients with biopsy-confirmed metabolic dysfunction–associated steatohepatitis and stage 2 or 3 fibrosis.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
